Brent Eberle: “Not all Cost-Plus is Created Equal”

January 10, 2024

Clients are cautious about how the cost in “cost-plus” programs is determined, how rebates factor in and the benchmarks used, says Navitus’s Brent Eberle.

More About BRENT EBERLE

As Senior Vice President, Chief Pharmacy Officer, Brent oversees Navitus’ health strategies division, which is responsible for clinical and population health initiatives, drug utilization review programs, formulary and rebate management, and specialty pharmacy operations.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Navigating with a trusted partner

Now Available: 9th Annual Drug Trend Report

Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.

Related blogs

Navigating Healthcare and Improving Outcomes

Navitus Learning & Development Team Named Top 10 by OnCon Icon Awards

Navitus Learning & Development Team Named Top 10 by OnCon Icon Awards

We’re thrilled to share that we’ve been recognized for having one of the Top 10 Learning and Development (L&D) Teams by the prestigious OnConferences (OnCon) Icon Awards. The OnCon Icon Awards celebrate outstanding achievements of top…

previous arrow
next arrow